<style type="text/css">body p { margin-bottom: 10px; text-align: Justify; } .about_the_doctor ul{ padding-left: 40px; margin-bottom: 10px; } </style> <p>I have been affiliated with the Division of Stem Cell Transplant and Cellular Therapy Program &ndash; Henry Ford Health System since April 2020. Previously, I worked in similar positions at Spectrum Health Cancer Center, Grand Rapids, MI for 6 years and Karmanos Cancer Center/ Wayne State University, Detroit, MI for approximately thirteen years. The Stem Cell Transplant and Cellular Therapy Program uses a comprehensive, multidisciplinary team approach to evaluate and treat patients who are candidates for bone marrow or peripheral blood stem cell transplant. As a Program Director I provide the quality and regulatory oversight. My primary research interest is in developing innovative treatment and supportive strategies for patients undergoing Stem cell transplant. I have been involved as a principal investigator in numerous investigator-initiated, pharmaceutical and cooperative group studies. I have been very actively involved in the Southwestern Oncology Group, Myeloma Committee and was coordinator of a National Clinical Trial, that determined one of the standards of care option for myeloma patients.</p> <p><strong>Contribution to Science</strong></p> <p>I have been actively involved in clinical research since 2001. My research interest is focused on designing clinical trials with innovative treatment strategies and supportive care for patients undergoing bone marrow transplant. I have extensively published on these topics in leading medical peer reviewed journal. In addition, I have also presented my scientific work at national and International conferences. I have been actively involved in SWOG myeloma committee since 2003 and have been coordinator of four national myeloma studies. One of these trials was published in Lancet and would change the standard of care. I have also assisted in examining new mobilization strategies for patients undergoing autologous stem cell transplant. My previous work in this field has increased understanding in the use of proteasome inhibitors and demonstrates the need for further work in this important area.&nbsp;</p> <p><strong>Research Support</strong></p> <p>I have received funding for investigator-initiated studies for multiple trials during my career at Wayne State University/Karmanos Cancer Center. I always had one of the highest accrual in the pharmaceutical studies and completed trials successfully after initiation. Recently we had the third highest accrual in a pharmaceutical study at Spectrum Health which was completed in record time.</p> <p>&nbsp;</p> Read More

<style type="text/css">body p { margin-bottom: 10px; text-align: Justify; } .about_the_doctor ul{ padding-left: 40px; margin-bottom: 10px; } </style> <p>Trained at premier medical institutes in India and at the Imperial College School of Medicine, Hammersmith Hospital, London, UK, Dr. Jyoti Wadhwa, has received clinical training in Hematological Malignancies including Stem Cell Transplant. She has subsequently served as the assistant professor of medical oncology at IRCH in AIIMS. Deputy Secretary of the National Academy of Medical Sciences, India, Dr. Wadhwa has also authored a book on breast cancer and been indicted in to associations such as the Indo &ndash; American Cancer Association, the American Society of Clinical Oncology and the European Society of Medical Oncology.</p> Read More

<style type="text/css">body p { margin-bottom: 10px; text-align: Justify; } .about_the_doctor ul{ padding-left: 40px; margin-bottom: 10px; } </style> <p>Dr. Gauri Kapoor is an alumnus of Lady Hardinge Medical College, New Delhi. She earned her PhD in Molecular Oncology from University of Delhi (ACBR).</p> <p>Dr. Gauri Kapoor is a leading Pediatric Oncologist of National stature, she carries an experience of 26 years in Pediatric (Medical) Oncology. She has also worked with Tata Memorial Hospital, Mumbai and St. Jude Children&#39;s Research Hospital, Memphis, USA. She is a recipient of Heinz fellowship by Royal College of Pediatrics and Child Health, London.</p> <p>Currently, she is Director and Head of Department of Pediatric Hematology - Oncology, Rajiv Gandhi Cancer Institute &amp; Research Centre. She joined RGCI&amp;RC in May 1997 and developed the Department of Pediatrics to its current premier status. National Board of Examination recognizes the Department for fellowship training of 2 post graduates in the subspecialty every year since 2008.</p> <p>Dr Kapoor has donned many hats and chaired many committees with her dynamic leadership. She is currently the chairperson of the Pediatric Hematology Oncology chapter of Indian Academy of Pediatrics, Chair InPOG Late effects committee of IAPs and chairperson of Infection Control Committee, RGCI&amp;RC. In recognition of her administrative skills she holds the additional responsibility of Medical Director of our Institute&#39;s Nitibagh facility in South Delhi. Her interest in academics and research is well known and she has more than 75 publications in peer reviewed journals.</p> <p>Her areas of interest include pediatric leukemias, molecular oncology, stem cell transplant, survivorship and awareness programs for childhood cancer for general public as well as practitioners.</p> Read More

<p>Dr. Surasit Issarachai, a hematologist and oncologist&nbsp; who received his medical degree&nbsp;with First Class Honor at Siriraj Hospital, Mahidol University, Thailand, and was a resident at&nbsp;University of Washington and Fred Hutchinson Cancer Research Center, Seattle, USA. Dr. Surasit Issarachai, a diplomat of American and Thai Medical Boards, serves patients at Bumrungrad International Hospital.</p> Read More

<style type="text/css">body p { margin-bottom: 10px; text-align: Justify; } .about_the_doctor ul{ padding-left: 40px; margin-bottom: 10px; } </style> <p>Assoc. Prof. Col. Dr. Wichean is a hematologist-oncologist specializing in the diagnosis, treatment and prevention of blood diseases and cancers such as hemophilia, leukemia and lymphoma. With more than 30 years of experience treating complex and difficult to treat blood diseases and cancers, Dr. Wichean has become one of the most experienced doctors in the world.&nbsp;</p> <p>Dr. Wichean often travels to speak at annual meetings and seminars around the world. He is in high demand due to his expertise and special clinical interests in stem cell transplantation and hematologic malignancy. His passion for healthcare is highlighted with his fellowship at the prestigious Mayo Clinic in Minnesota, as well as his ongoing position as an educator at Mahidol University in Thailand, not to mention his current role as a doctor at our very own Bumrungrad International Hospital in Bangkok, Thailand.</p> <p>When he isn&rsquo;t busy teaching or practicing medicine, Dr. Wichean enjoys reading, writing and traveling with his friends and family.&nbsp;</p> Read More

<style type="text/css">body p { margin-bottom: 10px; text-align: Justify; } .about_the_doctor ul{ padding-left: 40px; margin-bottom: 10px; } </style> <p>Dr. Amit Rauthan is one of the leading Doctors for Cancer Care at Manipal Hospital HAL Airport Road - Bengaluru. Dr. Amit Rauthan&#39;s area of expertise are:&nbsp;</p> <ul> <li>Immunotherapy in Cancer management</li> <li>Blood and Marrow Transplant, Hematological Malignancies, Solid Organ, Cancers like Breast, Gastrointestinal, Ovarian and Head &amp; Neck Cancers.</li> <li>Targeted therapies in Cancer</li> <li>Molecular Oncology</li> <li>Personalized cancer management</li> <li>Integration of chemotherapy and biological therapies in Cancer management</li> <li>He has more than 17 years of experience in treating cancer patients</li> </ul> Read More